Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 53 entries
Sorted by: Best Match Show Resources per page
Interinstrumental method transfer of a capillary electrophoretic separation of angiotensin II and five derivatives: Evaluation and update of earlier developed guidelines.

Electrophoresis

De Cock B, Van Eeckhaut A, Stiens J, Mangelings D, Vander Heyden Y.
PMID: 26202748
Electrophoresis. 2015 Nov;36(21):2658-2664. doi: 10.1002/elps.201500273. Epub 2015 Sep 07.

The increased interest in the separation of peptides, proteins, immunoglobulins, and polynucleotides, led to an increased demand for appropriate analytical methodologies and instrumentation. CE, because of its unique separation mechanism and high efficiency, is frequently used in the analysis...

Cite
De Cock B, Van Eeckhaut A, Stiens J, et al. Interinstrumental method transfer of a capillary electrophoretic separation of angiotensin II and five derivatives: Evaluation and update of earlier developed guidelines. Electrophoresis. 2015;36(21):2658-2664doi: 10.1002/elps.201500273.
De Cock, B., Van Eeckhaut, A., Stiens, J., Mangelings, D., & Vander Heyden, Y. (2015). Interinstrumental method transfer of a capillary electrophoretic separation of angiotensin II and five derivatives: Evaluation and update of earlier developed guidelines. Electrophoresis, 36(21), 2658-2664. https://doi.org/10.1002/elps.201500273
De Cock, Bart, et al. "Interinstrumental method transfer of a capillary electrophoretic separation of angiotensin II and five derivatives: Evaluation and update of earlier developed guidelines." Electrophoresis vol. 36,21 (2015): 2658-2664. doi: https://doi.org/10.1002/elps.201500273
De Cock B, Van Eeckhaut A, Stiens J, Mangelings D, Vander Heyden Y. Interinstrumental method transfer of a capillary electrophoretic separation of angiotensin II and five derivatives: Evaluation and update of earlier developed guidelines. Electrophoresis. 2015 Nov;36(21):2658-2664. doi: 10.1002/elps.201500273. Epub 2015 Sep 07. PMID: 26202748.
Copy Download .nbib Format: NLM
Angiotensins and Huntington's Disease: A Study on Immortalized Progenitor Striatal Cell Lines.

Frontiers in endocrinology

De Mello WC, Gerena Y, Ayala-Peña S.
PMID: 28596754
Front Endocrinol (Lausanne). 2017 May 24;8:108. doi: 10.3389/fendo.2017.00108. eCollection 2017.

Neurons from mouse models of Huntington's disease (HD) exhibit altered electrophysiological properties, potentially contributing to neuronal dysfunction and neurodegeneration. The renin-angiotensin system (RAS) is a potential contributor to the pathophysiology of neurodegenerative diseases. However, the role of angiotensin II...

Cite
De Mello WC, Gerena Y, Ayala-Peña S. Angiotensins and Huntington's Disease: A Study on Immortalized Progenitor Striatal Cell Lines. Front Endocrinol (Lausanne). 2017;8:108doi: 10.3389/fendo.2017.00108.
De Mello, W. C., Gerena, Y., & Ayala-Peña, S. (2017). Angiotensins and Huntington's Disease: A Study on Immortalized Progenitor Striatal Cell Lines. Frontiers in endocrinology, 8108. https://doi.org/10.3389/fendo.2017.00108
De Mello, Walmor C, et al. "Angiotensins and Huntington's Disease: A Study on Immortalized Progenitor Striatal Cell Lines." Frontiers in endocrinology vol. 8 (2017): 108. doi: https://doi.org/10.3389/fendo.2017.00108
De Mello WC, Gerena Y, Ayala-Peña S. Angiotensins and Huntington's Disease: A Study on Immortalized Progenitor Striatal Cell Lines. Front Endocrinol (Lausanne). 2017 May 24;8:108. doi: 10.3389/fendo.2017.00108. eCollection 2017. PMID: 28596754; PMCID: PMC5442183.
Copy Download .nbib Format: NLM
A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases.

Frontiers in endocrinology

Wright JW, Kawas LH, Harding JW.
PMID: 24298267
Front Endocrinol (Lausanne). 2013 Oct 25;4:158. doi: 10.3389/fendo.2013.00158.

The brain renin-angiotensin system (RAS) has available the necessary functional components to produce the active ligands angiotensins II (AngII), angiotensin III, angiotensins (IV), angiotensin (1-7), and angiotensin (3-7). These ligands interact with several receptor proteins including AT1, AT2, AT4,...

Cite
Wright JW, Kawas LH, Harding JW. A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases. Front Endocrinol (Lausanne). 2013;4:158doi: 10.3389/fendo.2013.00158.
Wright, J. W., Kawas, L. H., & Harding, J. W. (2013). A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases. Frontiers in endocrinology, 4158. https://doi.org/10.3389/fendo.2013.00158
Wright, John W, et al. "A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases." Frontiers in endocrinology vol. 4 (2013): 158. doi: https://doi.org/10.3389/fendo.2013.00158
Wright JW, Kawas LH, Harding JW. A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases. Front Endocrinol (Lausanne). 2013 Oct 25;4:158. doi: 10.3389/fendo.2013.00158. PMID: 24298267; PMCID: PMC3829467.
Copy Download .nbib Format: NLM
Endogenous angiotensins and catecholamines do not reduce skin blood flow or prevent hypotension in preterm piglets.

Physiological reports

Eiby YA, Lumbers ER, Staunton MP, Wright LL, Colditz PB, Wright IM, Lingwood BE.
PMID: 25538149
Physiol Rep. 2014 Dec 23;2(12). doi: 10.14814/phy2.12245. Print 2014 Dec 01.

Endocrine control of cardiovascular function is probably immature in the preterm infant; thus, it may contribute to the relative ineffectiveness of current adrenergic treatments for preterm cardiovascular compromise. This study aimed to determine the cardiovascular and hormonal responses to...

Cite
Eiby YA, Lumbers ER, Staunton MP, et al. Endogenous angiotensins and catecholamines do not reduce skin blood flow or prevent hypotension in preterm piglets. Physiol Rep. 2014;2(12)doi: 10.14814/phy2.12245.
Eiby, Y. A., Lumbers, E. R., Staunton, M. P., Wright, L. L., Colditz, P. B., Wright, I. M., & Lingwood, B. E. (2014). Endogenous angiotensins and catecholamines do not reduce skin blood flow or prevent hypotension in preterm piglets. Physiological reports, 2(12), . https://doi.org/10.14814/phy2.12245
Eiby, Yvonne A, et al. "Endogenous angiotensins and catecholamines do not reduce skin blood flow or prevent hypotension in preterm piglets." Physiological reports vol. 2,12 (2014). doi: https://doi.org/10.14814/phy2.12245
Eiby YA, Lumbers ER, Staunton MP, Wright LL, Colditz PB, Wright IM, Lingwood BE. Endogenous angiotensins and catecholamines do not reduce skin blood flow or prevent hypotension in preterm piglets. Physiol Rep. 2014 Dec 23;2(12). doi: 10.14814/phy2.12245. Print 2014 Dec 01. PMID: 25538149; PMCID: PMC4332223.
Copy Download .nbib Format: NLM
Angiotensins and Alzheimer's disease: a bench to bedside overview.

Alzheimer's research & therapy

Kehoe PG.
PMID: 19674436
Alzheimers Res Ther. 2009 Jul 09;1(1):3. doi: 10.1186/alzrt3.

The pathology of Alzheimer's disease (AD) features amyloid beta peptide deposition, intracellular neurofibrillary tangles and deficits in the cholinergic pathway. Abnormal blood pressure is recognised as a risk factor for the development of AD, although the underlying mechanisms remain...

Cite
Kehoe PG. Angiotensins and Alzheimer's disease: a bench to bedside overview. Alzheimers Res Ther. 2009;1(1):3doi: 10.1186/alzrt3.
Kehoe, P. G. (2009). Angiotensins and Alzheimer's disease: a bench to bedside overview. Alzheimer's research & therapy, 1(1), 3. https://doi.org/10.1186/alzrt3
Kehoe, Patrick G. "Angiotensins and Alzheimer's disease: a bench to bedside overview." Alzheimer's research & therapy vol. 1,1 (2009): 3. doi: https://doi.org/10.1186/alzrt3
Kehoe PG. Angiotensins and Alzheimer's disease: a bench to bedside overview. Alzheimers Res Ther. 2009 Jul 09;1(1):3. doi: 10.1186/alzrt3. PMID: 19674436; PMCID: PMC2719108.
Copy Download .nbib Format: NLM
The renin-angiotensin system in the pituitary gland.

Trends in endocrinology and metabolism: TEM

Deschepper CF.
PMID: 18411174
Trends Endocrinol Metab. 1991 May-Jun;2(3):104-7. doi: 10.1016/s1043-2760(05)80005-0.

There is evidence that angiotensin II, in addition to being generated in the circulating blood, is synthesized in the anterior pituitary lobe and other endocrine tissues. Angiotensin II produced locally may act on pituitary cell receptors to modulate or...

Cite
Deschepper CF. The renin-angiotensin system in the pituitary gland. Trends Endocrinol Metab. 1991;2(3):104-7doi: 10.1016/s1043-2760(05)80005-0.
Deschepper, C. F. (1991). The renin-angiotensin system in the pituitary gland. Trends in endocrinology and metabolism: TEM, 2(3), 104-7. https://doi.org/10.1016/s1043-2760(05)80005-0
Deschepper, C F. "The renin-angiotensin system in the pituitary gland." Trends in endocrinology and metabolism: TEM vol. 2,3 (1991): 104-7. doi: https://doi.org/10.1016/s1043-2760(05)80005-0
Deschepper CF. The renin-angiotensin system in the pituitary gland. Trends Endocrinol Metab. 1991 May-Jun;2(3):104-7. doi: 10.1016/s1043-2760(05)80005-0. PMID: 18411174.
Copy Download .nbib Format: NLM
From Agonist to Antagonist: Modulation of the Physiological Action of Angiotensins by Protein Conjugation-Hemodynamics and Behavior.

Frontiers in pharmacology

Zamolodchikova TS, Tolpygo SM, Kotov AV.
PMID: 34803713
Front Pharmacol. 2021 Nov 03;12:772217. doi: 10.3389/fphar.2021.772217. eCollection 2021.

No abstract available.

Cite
Zamolodchikova TS, Tolpygo SM, Kotov AV. From Agonist to Antagonist: Modulation of the Physiological Action of Angiotensins by Protein Conjugation-Hemodynamics and Behavior. Front Pharmacol. 2021;12:772217doi: 10.3389/fphar.2021.772217.
Zamolodchikova, T. S., Tolpygo, S. M., & Kotov, A. V. (2021). From Agonist to Antagonist: Modulation of the Physiological Action of Angiotensins by Protein Conjugation-Hemodynamics and Behavior. Frontiers in pharmacology, 12772217. https://doi.org/10.3389/fphar.2021.772217
Zamolodchikova, Tatyana S, et al. "From Agonist to Antagonist: Modulation of the Physiological Action of Angiotensins by Protein Conjugation-Hemodynamics and Behavior." Frontiers in pharmacology vol. 12 (2021): 772217. doi: https://doi.org/10.3389/fphar.2021.772217
Zamolodchikova TS, Tolpygo SM, Kotov AV. From Agonist to Antagonist: Modulation of the Physiological Action of Angiotensins by Protein Conjugation-Hemodynamics and Behavior. Front Pharmacol. 2021 Nov 03;12:772217. doi: 10.3389/fphar.2021.772217. eCollection 2021. PMID: 34803713; PMCID: PMC8595096.
Copy Download .nbib Format: NLM
Interaction Between the Angiotensin-(1-7) Mas Receptor and the Dopamine D2 Receptor: Implications in Inflammation.

Hypertension (Dallas, Tex. : 1979)

Rukavina Mikusic NL, Silva MG, Mazzitelli LR, Santos RAS, Gómez KA, Grecco HE, Gironacci MM.
PMID: 33677980
Hypertension. 2021 May 05;77(5):1659-1669. doi: 10.1161/HYPERTENSIONAHA.120.16614. Epub 2021 Mar 08.

[Figure: see text].

Cite
Rukavina Mikusic NL, Silva MG, Mazzitelli LR, et al. Interaction Between the Angiotensin-(1-7) Mas Receptor and the Dopamine D2 Receptor: Implications in Inflammation. Hypertension. 2021;77(5):1659-1669doi: 10.1161/HYPERTENSIONAHA.120.16614.
Rukavina Mikusic, N. L., Silva, M. G., Mazzitelli, L. R., Santos, R. A. S., Gómez, K. A., Grecco, H. E., & Gironacci, M. M. (2021). Interaction Between the Angiotensin-(1-7) Mas Receptor and the Dopamine D2 Receptor: Implications in Inflammation. Hypertension (Dallas, Tex. : 1979), 77(5), 1659-1669. https://doi.org/10.1161/HYPERTENSIONAHA.120.16614
Rukavina Mikusic, Natalia L, et al. "Interaction Between the Angiotensin-(1-7) Mas Receptor and the Dopamine D2 Receptor: Implications in Inflammation." Hypertension (Dallas, Tex. : 1979) vol. 77,5 (2021): 1659-1669. doi: https://doi.org/10.1161/HYPERTENSIONAHA.120.16614
Rukavina Mikusic NL, Silva MG, Mazzitelli LR, Santos RAS, Gómez KA, Grecco HE, Gironacci MM. Interaction Between the Angiotensin-(1-7) Mas Receptor and the Dopamine D2 Receptor: Implications in Inflammation. Hypertension. 2021 May 05;77(5):1659-1669. doi: 10.1161/HYPERTENSIONAHA.120.16614. Epub 2021 Mar 08. PMID: 33677980.
Copy Download .nbib Format: NLM
Activation of the Human Angiotensin-(1-12)-Chymase Pathway in Rats With Human Angiotensinogen Gene Transcripts.

Frontiers in cardiovascular medicine

Ferrario CM, VonCannon J, Ahmad S, Wright KN, Roberts DJ, Wang H, Yamashita T, Groban L, Cheng CP, Collawn JF, Dell'Italia LJ, Varagic J.
PMID: 31803758
Front Cardiovasc Med. 2019 Nov 15;6:163. doi: 10.3389/fcvm.2019.00163. eCollection 2019.

Angiotensin-(1-12) [Ang-(1-12)], an alternate substrate for tissue angiotensin II (Ang II) formation, underscores the importance of alternative renin-independent pathway(s) for the generation of angiotensins. Since renin enzymatic activity is species-specific, a transgenic model of hypertension due to insertion of...

Cite
Ferrario CM, VonCannon J, Ahmad S, et al. Activation of the Human Angiotensin-(1-12)-Chymase Pathway in Rats With Human Angiotensinogen Gene Transcripts. Front Cardiovasc Med. 2019;6:163doi: 10.3389/fcvm.2019.00163.
Ferrario, C. M., VonCannon, J., Ahmad, S., Wright, K. N., Roberts, D. J., Wang, H., Yamashita, T., Groban, L., Cheng, C. P., Collawn, J. F., Dell'Italia, L. J., & Varagic, J. (2019). Activation of the Human Angiotensin-(1-12)-Chymase Pathway in Rats With Human Angiotensinogen Gene Transcripts. Frontiers in cardiovascular medicine, 6163. https://doi.org/10.3389/fcvm.2019.00163
Ferrario, Carlos M, et al. "Activation of the Human Angiotensin-(1-12)-Chymase Pathway in Rats With Human Angiotensinogen Gene Transcripts." Frontiers in cardiovascular medicine vol. 6 (2019): 163. doi: https://doi.org/10.3389/fcvm.2019.00163
Ferrario CM, VonCannon J, Ahmad S, Wright KN, Roberts DJ, Wang H, Yamashita T, Groban L, Cheng CP, Collawn JF, Dell'Italia LJ, Varagic J. Activation of the Human Angiotensin-(1-12)-Chymase Pathway in Rats With Human Angiotensinogen Gene Transcripts. Front Cardiovasc Med. 2019 Nov 15;6:163. doi: 10.3389/fcvm.2019.00163. eCollection 2019. PMID: 31803758; PMCID: PMC6872498.
Copy Download .nbib Format: NLM
The Influence of Ace-Inhibition by Captopril on Renal Formation and Metabolism of Angiotensins I and II in Patients with Reno-Vascular Hypertension.

Scandinavian journal of urology and nephrology

Hesse B, Ramussen S, Giese J, Nielsen MD, Høilund-Carlsen PF.
PMID: 27786003
Scand J Urol Nephrol. 1984 Jul;18:45-48. doi: 10.1080/00365599.1984.11783714.

Fourteen patients with hypertension of presumed renovascular etiology were studied by renal vein catheterization. Unilateral renin secretion was found in 8 patients. In 4 of these patients a positive veno-arterial difference of plasma angiotensin I concentration (PAI) across the...

Cite
Hesse B, Ramussen S, Giese J, et al. The Influence of Ace-Inhibition by Captopril on Renal Formation and Metabolism of Angiotensins I and II in Patients with Reno-Vascular Hypertension. Scand J Urol Nephrol. 1984;18:45-48doi: 10.1080/00365599.1984.11783714.
Hesse, B., Ramussen, S., Giese, J., Nielsen, M. D., & Høilund-Carlsen, P. F. (1984). The Influence of Ace-Inhibition by Captopril on Renal Formation and Metabolism of Angiotensins I and II in Patients with Reno-Vascular Hypertension. Scandinavian journal of urology and nephrology, 1845-48. https://doi.org/10.1080/00365599.1984.11783714
Hesse, Birger, et al. "The Influence of Ace-Inhibition by Captopril on Renal Formation and Metabolism of Angiotensins I and II in Patients with Reno-Vascular Hypertension." Scandinavian journal of urology and nephrology vol. 18 (1984): 45-48. doi: https://doi.org/10.1080/00365599.1984.11783714
Hesse B, Ramussen S, Giese J, Nielsen MD, Høilund-Carlsen PF. The Influence of Ace-Inhibition by Captopril on Renal Formation and Metabolism of Angiotensins I and II in Patients with Reno-Vascular Hypertension. Scand J Urol Nephrol. 1984 Jul;18:45-48. doi: 10.1080/00365599.1984.11783714. PMID: 27786003.
Copy Download .nbib Format: NLM
Kallikrein/K1, Kinins, and ACE/Kininase II in Homeostasis and in Disease Insight From Human and Experimental Genetic Studies, Therapeutic Implication.

Frontiers in medicine

Alhenc-Gelas F, Bouby N, Girolami JP.
PMID: 31316987
Front Med (Lausanne). 2019 Jun 27;6:136. doi: 10.3389/fmed.2019.00136. eCollection 2019.

Kallikrein-K1 is the main kinin-forming enzyme in organs in resting condition and in several pathological situations whereas angiotensin I-converting enzyme/kininase II (ACE) is the main kinin-inactivating enzyme in the circulation. Both ACE and K1 activity levels are genetic traits...

Cite
Alhenc-Gelas F, Bouby N, Girolami JP. Kallikrein/K1, Kinins, and ACE/Kininase II in Homeostasis and in Disease Insight From Human and Experimental Genetic Studies, Therapeutic Implication. Front Med (Lausanne). 2019;6:136doi: 10.3389/fmed.2019.00136.
Alhenc-Gelas, F., Bouby, N., & Girolami, J. P. (2019). Kallikrein/K1, Kinins, and ACE/Kininase II in Homeostasis and in Disease Insight From Human and Experimental Genetic Studies, Therapeutic Implication. Frontiers in medicine, 6136. https://doi.org/10.3389/fmed.2019.00136
Alhenc-Gelas, Francois, et al. "Kallikrein/K1, Kinins, and ACE/Kininase II in Homeostasis and in Disease Insight From Human and Experimental Genetic Studies, Therapeutic Implication." Frontiers in medicine vol. 6 (2019): 136. doi: https://doi.org/10.3389/fmed.2019.00136
Alhenc-Gelas F, Bouby N, Girolami JP. Kallikrein/K1, Kinins, and ACE/Kininase II in Homeostasis and in Disease Insight From Human and Experimental Genetic Studies, Therapeutic Implication. Front Med (Lausanne). 2019 Jun 27;6:136. doi: 10.3389/fmed.2019.00136. eCollection 2019. PMID: 31316987; PMCID: PMC6610447.
Copy Download .nbib Format: NLM
Role of aminopeptidases in the neuroendocrine control of blood pressure in experimental animals.

Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion

Banegas I, Ramírez M, Alba F, Vives F, de Gasparo M, Belén Segarra A, Hermoso F, Durán R, Prieto I.
PMID: 22974453
Endocrinol Nutr. 2008 Oct;55(9):402-8. doi: 10.1016/S1575-0922(08)75077-0. Epub 2009 Jan 07.

Control of blood pressure is partially accomplished by several proteolytic enzymes included in the renin-angiotensin system. These enzymes produce several peptides that form the active components of the system. Study of these enzymes is essential for a deep understanding...

Cite
Banegas I, Ramírez M, Alba F, et al. Role of aminopeptidases in the neuroendocrine control of blood pressure in experimental animals. Endocrinol Nutr. 2009;55(9):402-8doi: 10.1016/S1575-0922(08)75077-0.
Banegas, I., Ramírez, M., Alba, F., Vives, F., de Gasparo, M., Belén Segarra, A., Hermoso, F., Durán, R., & Prieto, I. (2008). Role of aminopeptidases in the neuroendocrine control of blood pressure in experimental animals. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 55(9), 402-8. https://doi.org/10.1016/S1575-0922(08)75077-0
Banegas, Inmaculada, et al. "Role of aminopeptidases in the neuroendocrine control of blood pressure in experimental animals." Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion vol. 55,9 (2008): 402-8. doi: https://doi.org/10.1016/S1575-0922(08)75077-0
Banegas I, Ramírez M, Alba F, Vives F, de Gasparo M, Belén Segarra A, Hermoso F, Durán R, Prieto I. Role of aminopeptidases in the neuroendocrine control of blood pressure in experimental animals. Endocrinol Nutr. 2008 Oct;55(9):402-8. doi: 10.1016/S1575-0922(08)75077-0. Epub 2009 Jan 07. Spanish. PMID: 22974453.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 53 entries